MENU
AVXL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Anavex Life Sciences (AVXL) Ownership - Who owns Anavex Life Sciences?
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
630 5th Avenue
Phone
+1 844 689-3939
Employees
40
Web
https://www.anavex.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
728.15M
P/E Ratio
N/A
Total Cash
120.78M
Projected Growth
N/A
Total Debt
88.23K
Revenue
N/A
Risk (Beta)
1.14
Dividend Yield
N/A
Total Cash/Share
1.42
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AVXL
Capitalization
728M
P/E Ratio
N/A
Risk (Beta)
1.14
Dividend Yield
N/A
Total Cash
121M
Total Cash/Share
1.42
Total Debt
88.2K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
111M
P/B Ratio
6.57
Cash Flow
N/A
Earnings
-0.55
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
85K
Current Ratio
9.45
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-45.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.17
Shares Held By Institutions
453M
Shares Outstanding - Current
85.1M
Total Liabilities
13.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-20.298
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of innovative drug compounds
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
630 5th Avenue
Phone
+1 844 689-3939
Employees
40
Web
https://www.anavex.com